BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core
Active Master IDIQ Awarded
- Federal agency
-
National Institute on Drug Abuse
- Awardees
- 3
- Task orders
- 5
- Obligated
- $52,339,939
Vehicle facts
- Opportunity
-
- NIH BRAIN Initiative: BRAIN Initiative Cell Atlas Network (BICAN) Special Notice · NIHNIMH75N95022R00031 · Posted Jun 17, 2021
- Agency
-
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- Combined task order value
-
- $52,339,939 Current, with exercised options
- $131,369,787 Potential, with all options
- Last date to order 53% complete
- Shared ceiling 35% used
- $149,000,000.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The National Institute on Drug Abuse (a component of the Department of Health and Human Services National Institutes of Health) established this Master IDIQ on January 31, 2023, to procure high-throughput DNA and RNA sequencing services supporting the BRAIN Initiative Cell Atlas Network (BICAN), a research program generating genomic and transcriptomic reference maps of mammalian brain cells and tissues. Ordering authority extends through January 30, 2030, providing roughly 3.5 years of remaining ordering window. The vehicle carries a shared ceiling of $149 million and is unrestricted (no set-aside).
Five task orders have been awarded since March 2023, all to unrestricted competitive awardees. Two primes dominate the vehicle: New York Genome Center, Inc. holds 2 orders with $69.9 million combined potential value, and The Broad Institute, Inc. holds 2 orders with $61.5 million combined potential value. University of Washington received one order valued at $10 thousand. Combined task-order potential value stands at $131.4 million, with $52.3 million obligated (40% of potential value). Ordering activity concentrated in the first two months of the vehicle's life (all five orders awarded by May 29, 2023); no new orders have been placed in the 3+ years since.
Task-order scope divides into sequencing operations (Task Areas 2 through 6) priced as cost-no-fee arrangements, and program coordination work (Task Area 1: Manual of Operations) priced as firm-fixed-price. The two largest orders to New York Genome Center and The Broad Institute contain ceiling values of $69.9 million and $61.5 million respectively and run through May 28, 2028. Three smaller Task Area 1 orders (manual-of-operations support) were issued at $5,000 to $38,000 ceilings; two of these received March 19, 2025 notices of termination for convenience under a Department of Government Efficiency cost-efficiency initiative.
Customer concentration tilts heavily toward the National Institute on Drug Abuse, which placed 2 orders representing $131.3 million of combined potential value. The National Institute of Mental Health placed 3 orders valued at $53 thousand combined.
Description
Create the BICAN Sequencing Core, an integrated network of DNA and RNA sequencing service providers to support the high-throughput genomic, epigenomic and transcriptomic sequencing needs of several research laboratories participating in the BICAN program. Awardees will function within an integrated network with BICAN research laboratories to perform DNA and RNA sequencing of libraries derived from isolated cells, nuclei and bulk tissue from the different brain regions of multiple mammalian species, with an emphasis on the human brain.
IDV awards
| Awardee | IDV award | Awarded |
|---|---|---|
| New York Genome Center, Inc. | 75N95023D00007 | |
| University Of Washington | 75N95023D00008 | |
| The Broad Institute, Inc. | 75N95023D00006 |
Latest task orders
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | The Broad Institute, Inc. | $29,619,800 | 57% |
| 2 | New York Genome Center, Inc. | $22,713,038 | 43% |
| 3 | University Of Washington | $7,101 | <1% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $52,339,939 | 100% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2026 | $3,450,482 |
| FY2025 | $16,115,329 |
| FY2024 | $16,398,968 |
| FY2023 | $16,375,159 |
Quick answers
What is the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core contract vehicle?
BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Institute on Drug Abuse (National Institutes of Health), awarded on January 31, 2023.
Which companies hold BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core?
3 companies hold BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core's IDV awards, one each. The latest went to New York Genome Center, Inc. on January 31, 2023. The awardees whose task orders obligated the most are The Broad Institute, Inc., New York Genome Center, Inc. and University Of Washington.
How much has been spent through BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core?
5 task orders have been placed under BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core, obligating $52,339,939.
What is the shared ceiling of BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core?
BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core's shared ceiling is $149,000,000; its task orders have used 35% of it.
Which agencies use BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core the most?
The departments whose task orders under BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core obligated the most are Department of Health and Human Services ($52,339,939).
How much was obligated through BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core in fiscal year 2025?
Task orders under BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core obligated $16,115,329 in fiscal year 2025.
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle